However, in an ovarian cancer model, Halder et al. reported that FAK inhibition reduced tumor burden and suppressed angiogenesis in part by blocking pericyte production of VEGF and lowering pericyte coverage of the tumor [66]. The gene discussed is PTK2; the disease is ovarian carcinoma.